APA (7th ed.) Citation

Glicksman, R., Kishan, A., Quon, H., Shabsovich, D., Juarez, J., Jiang, T., . . . Loblaw, A. (2022). Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. Clinical Oncology, 34(9), 581. https://doi.org/10.1016/j.clon.2022.05.002

Chicago Style (17th ed.) Citation

Glicksman, R.M, A.U Kishan, H. Quon, D. Shabsovich, J. Juarez, T. Jiang, M.L Steinberg, L. Zhang, and A. Loblaw. "Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy." Clinical Oncology 34, no. 9 (2022): 581. https://doi.org/10.1016/j.clon.2022.05.002.

MLA (9th ed.) Citation

Glicksman, R.M, et al. "Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy." Clinical Oncology, vol. 34, no. 9, 2022, p. 581, https://doi.org/10.1016/j.clon.2022.05.002.